Quick links:
- From Diabetes Breakthrough to Social Media Superstar
- What Is the “Ozempic Body”?
- The Benefits Are Real… But So Are the Risks
- What About Mental Health?
- When Weight Loss Goes Underground
- How to Get Ozempic in Australia Safely
- So… Trend, Transformation or Trouble?
- HIF Answers Your Frequently Asked Questions
Few medications have crossed from the doctor’s office into popular culture quite like Ozempic. Originally developed to help manage type 2 diabetes, it has become a household name, a celebrity talking point, a TikTok regular and, somehow, the inspiration for an entire body “type”.
According to UNSW Sydney, around half a million Australians are now regularly using GLP-1 medicines. Their growing use represents an important shift in the way we can treat conditions such as diabetes and obesity, but their extraordinary popularity has also pushed a very personal medical decision into the public spotlight.
It can be an uncomfortable conversation. There are people experiencing genuine improvements in their health, while the internet simultaneously debates “Ozempic Face”, celebrity bodies and who may or may not be taking what. Somewhere between those two worlds, healthcare and beauty culture have become unusually tangled.
At HIF, we think this deserves more than a before-and-after photo. So, let’s look at how we got here, what the so-called “Ozempic Body” really means, where the genuine benefits and risks lie, and what happens when a medical breakthrough becomes a beauty trend.
Long before Ozempic was trending, it was doing the considerably less glamorous job it was developed for: helping adults with type 2 diabetes manage their blood glucose.
Ozempic is the brand name for semaglutide, a medicine belonging to a group known as GLP-1 receptor agonists. GLP-1 is a hormone produced naturally by the body that plays a role in blood glucose regulation, digestion and appetite. Medicines that mimic its effects can help the pancreas release insulin when blood glucose is high, reduce glucose released by the liver and slow the movement of food through the stomach.
That last part also means people can feel fuller for longer and experience a reduction in appetite. HIF’s existing guide to Ozempic, how it works and who it is for explores the science in more detail. And this is where the Ozempic story starts to get interesting.
Weight loss emerged as a significant effect of GLP-1 treatment, opening up important possibilities for people living with obesity. As the University of Melbourne explains, newer weight-loss medicines can help some people achieve substantial weight loss, particularly alongside appropriate lifestyle support. That matters because obesity is far more complex than the old “eat less, move more” equation suggests.
That matters because obesity is far more complex than the old “eat less, move more” equation suggests. Genetics, hormones, medications, environment, mental wellbeing and socioeconomic circumstances can all play a role, making weight loss and maintaining it difficult for some people despite sustained lifestyle changes. GLP-1 medicines have added another potentially valuable tool for doctors and patients.
Then the internet got involved.
Celebrity speculation, dramatic transformations and TikTok helped turn a medical development into a cultural phenomenon. Trends such as “SkinnyTok” brought extreme thinness back into the social media spotlight, while Ozempic became so synonymous with weight loss that many people now know more about its alleged celebrity users than its original purpose.
Ozempic did not become less legitimate because it became famous. But the conversation around it became a lot less medical.
The “Ozempic Body” is not a medical term. It is an internet-created phrase used to describe visible body changes associated with significant or rapid weight loss while taking medicines such as Ozempic.
Its equally well-known relative, “Ozempic Face”, refers to changes such as reduced facial volume or a more gaunt appearance. Importantly, these changes are not unique to Ozempic. Significant weight loss, however it happens, can change the distribution of fat across the face and body.
The more interesting question is why we have given those changes a brand name at all. Turning the name of a prescription diabetes medicine into shorthand for an aesthetic says a lot about a social media culture that can reduce a complex health journey to a before-and-after photo and a trending sound.
Those photos can show that someone’s body changed, but they cannot show why the medication was prescribed, what health conditions were being managed, whether side effects occurred, how nutrition changed or how much medical support sat behind the result. They also cannot tell us whether the person scrolling past should be taking the same medicine.
That is where the conversation can become uncomfortable. The issue is not that someone has lost weight with medical support. The concern is when that outcome starts being presented as a body type everyone else should be trying to achieve.
At HIF, we would rather broaden the definition of progress. Better mobility, blood glucose control, energy, strength, cardiovascular health and sleep may not make quite as dramatic a TikTok transition, but they can tell us far more about someone’s health than the size of their jeans.
Once a medicine becomes as culturally loaded as Ozempic, nuance can struggle to compete for attention. Depending on which corner of the internet you visit, GLP-1 medicines are either the answer to weight management or something to be deeply suspicious of. The reality, unsurprisingly, sits somewhere in between.
For appropriate patients, the benefits can be significant. Ozempic can help people living with type 2 diabetes manage their blood glucose, while GLP-1 medicines more broadly have created new possibilities for obesity treatment. Describing medication as an “easy way out” also misses the complexity of obesity as a chronic condition and the very real health improvements treatment can provide.
But effective does not mean risk-free. The University of Queensland notes that nausea, vomiting, diarrhoea and constipation are among the commonly reported side effects of semaglutide, while less common but potentially serious complications can include gallbladder problems and pancreatitis.
| What GLP-1 treatment may offer | What also needs consideration |
|---|
| Improved blood glucose management | Nausea, vomiting, diarrhoea and constipation |
| Reduced appetite and increased feelings of fullness | Gastrointestinal discomfort |
| Meaningful weight loss for some people | Lean tissue can be lost alongside body fat |
| Improvements in health associated with weight reduction | Gallbladder complications |
| Another evidence-based option for obesity treatment | Pancreatitis is a rare but potentially serious risk |
| Treatment alongside broader lifestyle support | Longer-term effects continue to be researched |
Muscle loss is another part of significant weight loss that receives far less attention than the number on the scales. Weight loss can include lean tissue as well as fat, which makes adequate protein, good overall nutrition and appropriate physical activity important considerations during treatment. Appetite may have left the building, but the body’s nutritional requirements have not.
There are also important questions about longer-term safety that science is still working to answer. GLP-1 medicines have become widely used relatively quickly, and our understanding will continue to develop as larger numbers of people use them over longer periods. That uncertainty does not mean we should assume these medicines are unsafe, but nor should popularity be mistaken for a completed evidence base.
The scale of ongoing legal action in the United States adds another layer to that conversation. As of August 2026, 3,928 lawsuits were pending in a consolidated US federal multidistrict litigation involving alleged complications associated with Mounjaro and other GLP-1 medicines. (King Law) There are also approximately 200 claims concerning alleged vision loss, or NAION. These are allegations before the courts, not scientific findings of causation or findings that manufacturers are liable.
Still, thousands of legal claims are difficult to dismiss as background noise. They are concerning and reinforce why continued scientific research matters. We should neither sensationalise the cases nor pretend they do not exist. What we can say is that these are relatively new treatments at this scale of use, and researchers, regulators and healthcare professionals will continue building a clearer picture of their longer-term safety.
The relationship between GLP-1 medicines and mental health is more complex than asking whether Ozempic causes depression. Current evidence has not established a clear causal link, and recent Australian research provides some reassurance. A joint University of Notre Dame Australia and University of Western Australia study examining PBS data from 2013 to 2024 found no evidence that the introduction of GLP-1 medicines was associated with increased antidepressant use.
But the mental health conversation extends beyond the medicine itself. Ozempic has arrived in a digital culture already full of weight-loss advice, body comparisons and increasingly narrow ideas of what a “healthy” body should look like. For young people especially, repeatedly seeing dramatic transformations can turn someone else’s medical treatment into a personal benchmark: they changed their body, so should I?
That can feed into much broader concerns around body dissatisfaction, disordered eating and body dysmorphia. Someone does not need to take Ozempic to be affected by the culture surrounding it. Consuming a constant stream of shrinking bodies, celebrity speculation and rapid weight-loss content can reinforce the message that thinner is always better and that medication might be the shortcut to getting there.
At HIF, we think both sides of this conversation matter. Understanding whether GLP-1 medicines directly affect mental health requires ongoing scientific research, but we should also be thinking about the culture growing around them. An algorithm can be very good at showing us what is trending. It is considerably less qualified to tell us what our bodies need.
So far, we have been talking about regulated medicines used within healthcare. The risks change considerably when the search for weight loss moves outside the doctor’s office.
Strong demand and the desire for cheaper or easier access have created a market for products sold as semaglutide, GLP-1s or “peptides” through social media and overseas suppliers. The problem is simple but serious: you need to know what you are injecting into your body.
An ABC News investigation found significant inconsistencies in unapproved injectable peptides sold through social media. Some contained around 40% of the strength stated on their labels, while another contained approximately 190%.
Red flags to watch for include:
- prescription medicines offered without a prescription
- products sold through social media or unknown online sellers
- unapproved substances marketed as “research peptides”
- unclear manufacturing origins or ingredients
- products where the strength cannot be reliably verified.
The Therapeutic Goods Administration has also identified counterfeit products containing no GLP-1 ingredient at all. In another TGA safety alert, a counterfeit pen labelled as Ozempic was found to contain insulin after a serious adverse event was reported.
At that point, we are no longer weighing up the known benefits and side effects of Ozempic. We are dealing with an unknown substance in convincing packaging. A polished website or enthusiastic comment section is not pharmaceutical quality control. The biggest risk may not be Ozempic at all, but that what you have bought isn’t Ozempic in the first place.
So, if social media sellers and unregulated products are firmly off the table, what does safe access actually look like in Australia?
Ozempic is a prescription-only medicine, which means the right place to start is with a GP or relevant specialist. They can assess whether a GLP-1 medicine is appropriate for your health, discuss potential alternatives and explain costs and PBS eligibility. If prescribed, Ozempic should then be obtained through a legitimate pharmacy, with appropriate follow-up throughout treatment.
The TGA advises Australians to obtain prescription medicines through legitimate healthcare and pharmacy channels and warns against unregistered products sold through social media and other digital platforms.
It might not have the instant appeal of “add to cart”, but when it comes to prescription medication, the consultation, prescription and pharmacist are exactly the safeguards you want.
Perhaps Ozempic is all three, but not for the reasons the headlines sometimes suggest.
- The transformation is medical. GLP-1 medicines have given doctors another significant tool for managing diabetes and obesity, with meaningful health benefits for appropriate patients.
- The trend is cultural. A prescription medicine has become celebrity speculation, transformation content and even an aesthetic with its own nickname.
- The trouble is losing sight of the individual. What is appropriate for one person’s health is not automatically right for someone else, regardless of how compelling their results might look online.
At HIF, we aim to support a more sustainable and individual approach to health. Medication can absolutely be part of that picture when clinically appropriate, alongside the everyday things that support long-term wellbeing, from good nutrition and movement to sleep, preventive healthcare and professional support.
That proactive approach is reflected in the support available to eligible HIF members. Depending on their cover, members can explore HIF’s Health & Wellbeing Programs, including Healthy Weight For Life for eligible members seeking structured weight-management support. HIF also provides options through Healthy Lifestyle Cover, helping eligible members access support designed to proactively maintain their health and wellbeing.
Ultimately, the most useful question may not be “How do I get an Ozempic Body?” but “What would meaningfully improve my health?” The answer will look different for everyone, and that is exactly the point.
If GLP-1 medication is something you are considering, speak with your GP or specialist about your individual circumstances. You can also read HIF’s guide to Ozempic, how it works and who it is for, or explore our Healthy Lifestyle, Healthy Living and Nutrition resources for more ways to support your health.
What is Ozempic?
Ozempic is the brand name for semaglutide, a GLP-1 receptor agonist prescribed in Australia for the treatment of type 2 diabetes in appropriate patients. It mimics the action of the naturally occurring GLP-1 hormone, helping regulate blood glucose while also slowing digestion and affecting appetite. HIF’s guide to what Ozempic is and how it works explains the treatment in more detail.
What is the Ozempic Body?
“Ozempic Body” is a popular-culture term rather than a recognised medical condition. It generally describes visible changes associated with substantial or rapid weight loss while using medicines such as Ozempic. Many of these changes can also occur following significant weight loss through other methods.
What are the most common Ozempic side effects?
Common side effects can include nausea, vomiting, diarrhoea, constipation and other gastrointestinal symptoms. Less common but potentially serious complications have also been reported. The University of Queensland provides further information about the potential benefits and risks of semaglutide.
How do GLP-1 medications work?
GLP-1 receptor agonists mimic a hormone naturally produced by the body. They can help regulate blood glucose by influencing insulin and glucose production, slow the movement of food through the stomach and affect appetite and feelings of fullness. The precise effects and approved uses depend on the particular medicine.
How do you get Ozempic in Australia?
Ozempic is available by prescription in Australia. A GP or relevant specialist needs to assess whether it is clinically appropriate for you before providing a prescription. Depending on the reason for treatment and whether relevant eligibility requirements are met, the medicine may be accessed through the PBS or via a private prescription.
Is Ozempic available without a prescription?
No. Ozempic is a prescription-only medicine in Australia. Products offered without an appropriate prescription or medical assessment should be treated with caution, particularly when they are being sold through social media or unknown overseas websites.
Is it safe to buy Ozempic online?
Consumers should be extremely cautious about buying products claiming to be Ozempic or semaglutide from unknown online sellers. The TGA has warned Australians about counterfeit and unregistered weight-loss products that may contain incorrect amounts of an ingredient, a different ingredient or no GLP-1 medicine at all.
Does Ozempic increase depression risk?
The relationship between Ozempic and mental health is still being studied, and the picture is more complex than a simple yes or no. Current evidence has not established a clear causal link between Ozempic and depression. One Australian study analysing PBS dispensing data from 2013 to 2024 found no evidence that the introduction of GLP-1 medicines was associated with increased antidepressant use, but research into the broader and longer-term effects of these medicines is continuing.
Mental wellbeing can also be influenced by factors beyond the medication itself, particularly when weight, body image and significant physical changes are involved. If you experience changes in your mood or mental wellbeing while taking Ozempic or another GLP-1 medicine, speak with your GP or treating healthcare professional immeadiately.
Eligible HIF members can also explore HIF’s mental health and wellbeing support for additional resources and support.
What are the alternatives to Ozempic?
Other GLP-1 medicines and weight-management treatments are available in Australia, but the right option depends on why treatment is being considered, your medical history and other individual factors. A GP or specialist can discuss the available options and whether medication, lifestyle support or a combination of approaches is most appropriate.